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Background/aim: The present study was designed to explore antidiabetic and hepatoprotective potentials of Fraxinus angustifolia leaf
(FAL) and bark (FAB) extracts in vivo.
Materials and methods: Streptozotocin (STZ)-induced diabetic rats, pretreated with the extracts (25 and 50 mg/kg), were monitored
for fasting blood glucose (FBG) levels. Hepatoprotective potential was examined after injection of an excessive dose of paracetamol (10
g/60 kg) by analysis of biochemical parameters (transaminases, bilirubin), malondialdehyde (MDA) levels, and histological sections.
high performance liquid chromatography analysis was also performed for partial characterization.
Results: A considerable hypoglycemic effect was noticed 2 h after the STZ-induction, with a higher efficiency (P < 0.05) for FAL (68%)
as compared with FAB (57%). A significant (P < 0.05) reduction in MDA was observed for paracetamol-fed mice pretreated with
FAL (50 mg/kg), FAB (50 mg/kg), or both (25 mg/kg each) extracts, and the MDA levels for the three conditions were 0.290 ± 0.034,
0.340 ± 0.038, and 0.25 ± 0.058 nmoles/mg of liver tissue, respectively). Hence, simultaneous treatment provided a better protection.
Histological observations confirmed the higher hepatoprotective potential of FAL over FAB extracts
Conclusion: The obtained results indicate the possibility of pharmacological exploitation of F. angustifolia extracts in the treatment of
diabetes and associated liver diseases.
Key words: Fraxinus angustifolia, antidiabetic, hepatoprotective, lipid peroxidation, α-amylase

1. Introduction
Diabetes mellitus, a complex chronic pathological
condition, is considered a major health problem
worldwide. This metabolic disorder is characterized by
hyperglycemia and disturbances in carbohydrate, protein,
and fat metabolisms secondary to an absolute or relative
lack of insulin (1). Besides hyperglycemia, several other
factors including dyslipidemia or hyperlipidemia are
involved in the development of micro- and macrovascular
complications of diabetes, leading to morbidity and
mortality (2). For Algerian practitioners, diabetes
is considered a serious public health problem since,
according to the World Health Organization, 10% of the
Maghreb inhabitants were diagnosed with type-2 (noninsulin-dependent) diabetes, with 24.1 million persons
affected. Insulin therapy and other conventional drugs
are not devoid of adverse side effects in addition to their
unsatisfactory efficiency in certain cases, which urges the
* Correspondence: djatmani@yahoo.com
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quest for the development of more effective antidiabetic
natural agents. In fact, previous studies confirmed the
efficiency of several medicinal plants in diabetes (3,4).
Another therapeutic approach for treating diabetes is to
inhibit the carbohydrate-hydrolyzing enzymes such as
α-amylase, thus retarding the absorption of glucose in the
digestive tract.
Liver disease constitutes another endemic problem in
the world, causing the death of about 25,000 people annually
due to liver cirrhosis caused by hepatitis (5) and lesions
due to injury by free radical derivatives of paracetamol
(6). Since the latter generates lipid peroxidation, the
inhibition of the generation of free radicals is important in
the protection against paracetamol-induced hepatopathy
(7). In this perspective, natural antioxidants may play a
key role in hepatoprotection. However, even though there
is an increased assumption that natural products are safe,
scientific studies have shown that several phytochemicals
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can be cytotoxic, genotoxic, and carcinogenic when
consumed excessively and irrationally (8). The toxicity
of medicinal plants depends on many factors such as the
part of plant and the extraction solvent used, which will
determine the composition and biological activity of the
extracts as well as the bioavailability of their components.
Moreover, poor handling of raw or processed materials
may produce exogenous toxic contaminants, not inherent
as plant phytochemicals (9).
In recent years, several authors investigated the
antidiabetic potential of Algerian medicinal plants using
experimental animals (10,11). Some species of Fraxinus
have been examined for their hypoglycemic potential (12),
but no data are available concerning Fraxinus angustifolia.
The leaves and bark of this tree, endemic in Northwestern
Africa, are traditionally used as diuretic, antirheumatoid,
laxative, sudoriﬁc (13), hypotensive, hypoglycemic, and
antiseptic (14–16). Therefore, the aim of the present study
was to examine in vivo the subchronic toxicity and the
antidiabetic and hepatoprotective potentials of ethanolic
extracts of F. angustifolia. In order to understand the
mechanism of antidiabetic action, the α-amylase activity of
the extracts was also tested. Moreover, high performance
liquid chromatography (HPLC) profiles of the extracts
were established and compared with standards for partial
characterization.
2. Materials and methods
2.1. Preparation of plant extracts
Fresh leaves and barks of F. angustifolia were harvested from
Tizi Neftah, a remote place in the Province of Amizour,
Bejaia, northeastern Algeria. The plant was identified in
the Laboratory of botany (University of Bejaia) where a
specimen was deposited. The leaves and barks were airdried in the shade and ground to fine powders (63 µm
in diameter); they were extracted separately with ethanol
(1/4: w/v) at room temperature for 24 h. The extractive
liquids were evaporated to obtain dry crude hydroalcoholic
extracts of Fraxinus angustifolia leaves (FAL) and Fraxinus
angustifolia bark (FAB).
2.2. HPLC fractionation and analysis
Extracts of FAB and FAL (3 g) were fractionated by HPLC
with a photodiode array detector (HPLC-DAD) (pf 425–
250 Interchim, C8 column Zorbax, 150 × 21.5 mm (250
bars)) at a concentration of 100 g/L. The mobile phase
consisted of methanol (A) and water (B) with the following
elution gradient: 0 min 0% A 100% B, 26.0 min 100% A 0%
B; 26.1–29.4 0% A 100% B, 29.4–29.5 0% A 100% B. The
flow rate was 20 mL/min and the column temperature was
set at 25 °C.
Chemical characterization of FAL and FAB extracts was
carried out by comparing the detected polyphenol peaks
with respect to retention times with those of standard

chemicals (such as chlorogenic acid, tyrosol, benzoic
acid, caffeic acid, vanillic acid, syringic acid, sinapic acid,
ferulic acid, oleuropein, quercetin, luteolin, cinnamic acid,
and apigenin) that were monitored at 250 nm using the
same HPLC system. All standards were purchased from
Extrasynthese or Sigma-Aldrich. Identity and purity of the
chemical standards were assessed by HPLC analysis.
2.3. Laboratory animals
Albino male mice (25 ± 3 g) and Wistar rats of either
sex weighing 180–220 g obtained from Pasteur Institute
(Algiers, Algeria) were provided with standard food and
water ad libitum; the animals were kept in a constant
controlled environment (temperature of 23 ± 1° C, relative
humidity of 65 ± 5%, and 12/12 h light/dark cycle). After
two weeks of acclimatization to laboratory conditions,
experiments were conducted in strict compliance
with internationally accepted principles for work with
laboratory animals (directive N° 2010/63/EU of 22
September 2010, which updates and replaces directive N°
86/609/EEC of 24 November 1986).
2.4. Determination of total polyphenols and flavonoids
The quantification of total polyphenols was conducted
according to the Folin–Ciocalteu procedure (17), using
catechin as a standard. First, 0.1 mL of extract (3.1 mg/mL
in methanol), 0.5 mL of Folin–Ciocalteu (1/10) reagent,
and 1.5 mL of Na2CO3 (20%) were mixed. After incubation
for 1 h, absorbance was measured at 765 nm. Results were
expressed as mg of catechin equivalents per gram of extract
obtained from a regression curve. Flavonoid content was
determined using a colorimetric method (18) with some
modifications. Then 1 mL of extract (0.15 mg/mL in
methanol) was mixed with 0.5 mL of AlCl3 and incubated
for 10 min, after which the absorbance was measured at
430 nm. Results were calculated as mg rutin equivalents
per gram of extracts obtained from a regression curve.
2.5. Subchronic toxicity
Twenty-five Wistar male rats were randomized into 5
groups (n = 5) and administered orally daily doses of the
following solutions: group I received physiological saline
(0.9%); groups II and III received FAL and FAB extracts at
20 mg/kg, respectively; and groups IV and V were given
FAL and FAB extracts at 200 mg/kg, respectively. Rats were
weighted on a daily basis and observations were made
twice daily for mortality and changes in general behavior.
At the end of the experiment (28 days), mice were
anesthetized, sacrificed, and blood samples were collected
for determination of hematological and biochemical
parameters.
2.6. Antidiabetic activity in vivo
Diabetes was induced in Wistar rats fasted overnight by
an intraperitoneal injection of 60 mg/kg of a solution
of streptozotocin (STZ) (Sigma). Rats that developed
glycemia with glucose levels higher than 200 mg/dL 72

911

MEDJAHED et al. / Turk J Med Sci
h after STZ injection (19) were preselected and assigned
to 6 groups (n = 5): group I (control) received vehicle
(physiological saline 0.9%); group II received a reference
molecule, Diabenil (50 mg/kg); groups III and IV received
FAL and FAB extracts (25 mg/kg) respectively, and groups
V and VI received FAL and FAB extracts (50 mg/kg),
respectively. The volume of the suspension administered
was based on body weight measured immediately prior to
each dose (10 mL/kg). Blood withdrawn from the retro–
orbital sinuses of the eyes was collected in heparinized
tubes, after 1 and 2 h of treatment. Recovered blood
was then centrifuged at 1500 × g for 10 min for glucose
measurements using SPINREACT kit (cat. no-1001191).
2.7. α-Amylase inhibition assay
α-Amylase inhibition by FAL and FAB extracts was
assessed using the method of Hasenah et al. (20). First,
400 µL of substrate solution prepared by using potato
starch (0.5%) in phosphate buffer (20 mM, pH 6.9) and
containing sodium chloride (6.7 mM) was mixed with 40
µL of plant extract (75–250 µg/mL) and 160 µL of distilled
water. The enzymatic reaction was initiated by the addition
of 200 µL of Aspergillus oryzae α-amylase (4 units/mL)
(Sigma Aldrich) followed by incubation for 3 min at 25
°C. Subsequently, 200 µL of the reaction mixture was
added to 100 µL (96 mM) 3,5-dinitrosalicylic acid sodium
potassium tartrate (5.31 M) dissolved in NaOH (2 M) and
incubated at 85 °C for 15 min. After addition of 900 µL
of distilled water, the absorbance was measured at 540
nm. Enzyme inhibition was calculated using the following
formula: % inhibition = [1 – (At/Ac)] × 100, where At and
Ac are absorbances of the test solutions with and without
extract, respectively.
2.8. Hepatoprotective potential
The hepatoprotective effect of F. angustifolia ethanol
extracts against paracetamol-induced toxicity was
investigated using the method of Yeh and Hu (21). Forty
male albino mice (25 ± 2 g) were randomly allocated to
control and test groups (n = 8) in the following manner:
group I (negative control) received saline solution (0.9%);
group II (positive control) received an oral overdose of
paracetamol (10 g/60 kg) on day 1 and serum saline (0.9%)
on days 2 and 3; groups III, IV, and V were administered
paracetamol (10 g/60 kg) on day 1 and FAL (50 mg/kg),
FAB (50 mg/kg), and a mixture of both (25 mg/kg of each),
respectively, on days 2 and 3.
2.8.1. Estimation of biochemical parameters
At the end of the experiment, mice were anesthetized and
sacrificed. Blood samples were collected from their retro–
orbital sinus and their livers were removed for further
analysis. Blood samples were allowed to clot and sera
were separated by centrifugation (2500 × g, 37 °C), stored
at –20 °C until use for determination of the following
hematological and biochemical parameters: transaminases
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(aspartate transaminase (AST) (cat.no-HBE06), alanine
transaminase (ALT) (cat.no-HBE07), and total bilirubin)
using commercial kits (Cypress Diagnostics).
2.8.2. Lipid peroxidation assay
Mice livers were excised promptly, weighed, and washed
thoroughly in cold saline (0.9%). One gram of liver was
chopped into 4–5 volumes of Tris buffer (0.15 M, pH
7.4) and homogenized. Lipid peroxidation was assayed
according to standard procedures (22). Briefly, 1 mL
of normal saline and 2 mL of 10% trichloroacetic acid
(TCA) were added to 1 mL of tissue homogenate, and the
mixture was centrifuged (3000 × g, 10 min). Then 2 mL
of the obtained supernatant were removed, to which 0.5
mL of thiobarbituric acid (TBA) (1%) was added followed
by heating at 100 °C for 30 min. The absorbance of the
samples was measured at 532 nm and the MDA levels
were expressed as nmoles MDA/mg of liver tissue using
the extinction coefficient 1.56 × 105 M–1 cm–1 (23).
2.8.3. Histological analysis
Liver tissues isolated previously were fixed in 10% formalin
solution. Paraffin blocks were prepared after completing the
tissue processing in different grades of alcohol and xylene.
Sections (4 µm) were prepared from paraffin blocks using
a microtome and stained with hematoxylin and eosin.
Microscopic examinations were conducted to detect signs
of liver damage such as necrosis (neutrophil infiltration
and dilatation of sinusoids), steatoses (fat deposits), and
dilatation and congestion of the centrilobular vein.
3. Statistical analysis
Results were expressed as means ± standard deviation
for in vitro tests or standard error of the means (SEM)
for in vivo tests. Experimental data were analyzed using
GraphPad Prism 5.3 software. Analysis of variance
(ANOVA) was used, followed by Dunnett’s test. The results
were considered statistically significant at *P < 0.05, **P <
0.01, and ***P < 0.001.
4. Results
4.1. HPLC analysis
HPLC analysis of bark and leaf extracts (Figure 1) showed
profiles with retention times that coincided exactly with
some of these chemicals. Mainly, for bark, retention times
of fractions 1, 2, 6, and 8 coincided with tyrosol, caffeic
acid, pinoresinol, and luteolin, respectively. For leaves,
retention times of fractions 1, 2, and 3 were found identical
to those of oleuropein, quercetin, and cinnamic acid.
4.2. Determination of total polyphenols and flavonoids
Data shown in Table 1 indicate the presence of a substantial
amount of polyphenols in the FAB extract compared with
its FAL counterpart, while a greater amount of flavonoids
was found in the FAL than in the FAB extract.
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Figure 1. A) Chromatogram of standards: 1: chlorogenic acid; 2: tyrosol; 3: benzoic acid; 4: caffeic acid; 5: vanillic acid;
6: syringic acid; 7: sinapic acid; 8: ferulic acid; 9: oleuropein; 10: quercetin; 11: luteolin; 12: cinnamic acid; 13: apigenin.
B) Chromatogram of F. angustifolia leaf extract: F1: oleuropein; F2: cinnamic acid; F3: quercetin. C) HPLC chromatogram
of F. angustifolia bark extract: E1: tyrosol; E2: caffeic acid; E6: pinoresinol; E8: luteolin.
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Table 1. Determination of total polyphenols and flavonoids in Fraxinus angustifolia leaf and bark extracts.

Ethanol extract

Total polyphenols
mg Eq catechin/g extract

Total flavonoids
mg Eq rutin/g extract

FAL
194.05 ±14.08

FAL
100.29 ± 17.60

FAB
715.96±59.62

FAB
50.00 ± 17.64

FAL: F. angustifolia leaves; FAB: F. angustifolia bark.
150
*
Body weight gain (g)

4.3. Subchronic toxicity
Indications of toxicity are alterations in clinical signs such
as diarrhea, weight loss, agitation, hispid hair, convulsions,
tremors, dyspnea, and mortality (24). The close monitoring
of mice during the whole treatment period indicated no
such toxicity signs. Moreover, compared with the control
group, no significant loss or gain of weight for any of the
tested groups was observed during or at the end of the 28
days experiment (Figure 2).
No change in AST activity was observed in mice treated
with either FAL (81.5 ± 3.8 and 79.0 ± 3.3 IU/L at 20 and
200 mg/kg, respectively) or FAB (77.0 ± 3.8 and 72.7 ± 2.1
IU/L at 20 and 200 mg/kg, respectively). Nevertheless, with
respect to ALT, considered to be more specifically related
to liver problems, a slight and dose-dependent toxicity was
recorded in mice treated with FAL (45.5 ± 1.8 IU/L), while
FAB (28.2 ± 1.9 IU/L) (200 mg/kg) reduced significantly
the level of this enzyme (Table 2). At the same time, total
bilirubin was unchanged with FAB (0.73 ± 0.07 mg/
mL), but showed dose-dependent decreased levels with
FAL (0.56 ± 0.04 mg/mL) (Table 3). In addition, blood
sugar (1.03 ± 0.05 and 1.11 ± 0.04 g/L for FAL and FAB,
respectively) or cholesterol levels (0.51 ± 0.03 g/L; 0.44 ±
0.04 g/L for FAL and FAB, respectively) were not affected
(Table 3), while creatinine was either not altered for FAL at
20 mg/kg (9.80 ± 0.74 mg/mL) or significantly (P < 0.05)
reduced for FAL at 200 mg/kg (4.16 ± 0.17 mg/mL) and for
FAB at 200 mg/kg (4.06 ± 0. 35 mg/mL).

*

100

*
*

50

0

I

II

III
IV
Experimental group

V

Figure 2. Bodyweight gain after 28 experimental days. FAL:
Fraxinus angustifolia leaves, FAB: Fraxinus angustifolia bark. I:
Control, II: FAL 20 mg/kg, III: FAB 20 mg/kg, IV: FAL 200 mg/
kg, V: FAB 200 mg/kg. All values are expressed as means ± SEM
of six animals. One-way ANOVA followed by Dunnett’s test was
used for statistical signiﬁcance. *P < 0.05, compared with the
normal control group.

4.4. Antidiabetic activity
4.4.1. Antidiabetic activity in vivo
Induction of diabetes in experimental rats was conﬁrmed
by a considerable rise in fasting blood glucose (FBG) levels
(> 150 mg/dl) for the diabetic control rats (Figure 3). On
the other hand, FAL reduced FBG by 45% and 68% at 25

Table 2. Effect of prolonged administration (28 days) of F. angustifolia leaf and bark ethanol extracts on mean (± SEM) serum enzyme
parameters.
Groups

AST IU/L

ALT IU/L

ALP IU/L

I

73.0 ± 2.8a

31.6 ± 1.8b

236.0 ± 3.3b

II

81.5 ± 3.8c

39.0 ± 2.3c

234.0 ± 7.1b

III

77.0 ± 3.8ab

33.6 ± 2.6b

456.6 ± 6.9d

IV

79.0 ± 3.3ab

45.5 ± 1.8d

296.6 ± 10.3c

V

72.7 ± 2.1a

28.2 ± 1.9a

152.0 ± 3.8a

IU/L: International unit/L. AST: aspartate amino transferase. ALT: alanine amino transferase. ALP: alkaline phosphatase G-I: Control,
G-II: FAL 20 mg/kg, G-III: FAB 20 mg/kg, G-IV: FAL 200 mg/kg, G-V: FAB 200 mg/kg. Each value in the table is the mean ± (SEM) (n
= 6). Values in the same column sharing different letters are significantly different (P < 0.05) (ANOVA followed by Newman–Keuls).
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Tablea3. Effect of prolonged administration (28 days) of F. angustifolia ethanol leaf and bark extracts on mean (± SEM) biochemical
parameters.
Groups

Creat mg/mL

Glc g/L

Chol g/L

TBil mg/mL

I

8.60 ± 0.48d

1.01 ± 0.09 ab

0.47 ± 0.08ab

1.10 ± 0.15c

II

9.80 ± 0.74d

1.03 ± 0.05ab

0.59 ± 0.05c

1.02 ± 0.23c

III

4.94 ± 0.30b

1.11 ± 0.04b

0.42 ± 0.04a

0.73 ± 0.07b

IV

4.16 ± 0.17a

1.026 ± 0.03ab

0.51 ± 0.03bc

0.56 ± 0.04ab

V

4.06±0. 35a

0.98±0.12a

0.44±0.04ab

0.61 ± 0.25a

Creat: creatinine, Glc: glucose, Chol: cholesterol, TBil: Total bilirubin, G-I: Control, G-II: FAL 20 mg/kg, G-III: FAB 20 mg/kg, G-IV:
FAL 200 mg/kg, G-V: FAB 200 mg/kg. Each value in the table is the mean ± (SEM) (n = 6). Values in the same column sharing different
letters are significantly different (P < 0.05). (ANOVA followed by Newman–Keuls).
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Figure 3. Percent decrease of glucose after the first and second
hour of treatment. FAL: F. angustifolia leaves; FAB: F. angustifolia
barks. All values are expressed as means ± SEM of six animals.
One-way ANOVA followed by Dunnett’s test was used for
statistical signiﬁcance. *P < 0.05, compared with the Diabenil
group.

inhibition of a -amylase %

decrease of glucose %

100

*

60

*
***

40

*

**

***

20

and 50 mg/kg, respectively, compared to 26% and 57%
at the same respective doses for FAB. Diabenil (50 mg/
kg), a well-known antidiabetic drug, caused a significant
(P < 0.01) decrease of blood glucose (72%) after 2 h of
treatment, comparable (P > 0.05) with that of FAL at 50
mg/kg.
4.4.2. Antidiabetic activity in vitro: α-amylase inhibition
assay
In the α-amylase inhibition assay, the extracts exerted
a moderate, dose-dependent inhibition on this enzyme
(IC50 values of 187.42 and 360.75 µg/mL for FAL and FAB,
respectively) (Figure 4), significantly (P < 0.05) lower than
that of the standard acarbose (IC50 = 15.87 µg/mL).
4.5. Hepatoprotective potential
In order to estimate if liver necrosis was prevented by F.
angustifolia extracts after paracetamol treatment, three
parameters were evaluated: plasma transaminases, MDA
levels, and liver histology.

0
acarbose

FAL

FAB

Figure 4. Percent inhibition of α-amylase by Fraxinus angustifolia
ethanolic leaf and bark extracts. FAL: Fraxinus angustifolia
leaves. FAB: Fraxinus angustifolia bark. All values are expressed
as means ± SEM of six animals. One-way ANOVA followed by
Dunnett’s test was used for statistical signiﬁcance. *P < 0.05, **P
< 0.01, ***P < 0.001 compared with the acarbose group.

4.5.1. Blood parameters
Paracetamol significantly (P < 0.05) raised hepatic
enzyme levels (AST = 241.83 ± 67.33 IU/L, ALT = 66.66
± 15.25 IU/L) and total bilirubin (1.41 ± 0.40 mg/mL)
in the positive control group (Table 4, group II). While
the FAB extract (50 mg/kg) failed to protect liver cells,
the FAL extract led to a significant (P < 0.05) decrease in
transaminase levels (AST = 200.20 ± 35.89 IU/L; ALT =
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Table 4. Effect of F. angustifolia ethanol leaf and bark extracts on serum enzyme levels after treatment with paracetamol (10 g/60 kg).
Groups

AST IU/L

ALT IU/L

I

78.90 ± 9.30

59.5 ± 9.41

0.95 ± 0.48a

II

241.83 ± 67.33c

66.66 ± 15.25ab

1.41 ± 0.40b

III

200.20 ± 35.89cd

63.98 ± 9.45a

1.42 ± 0.35a

IV

236.94 ± 27.45d

84.34 ± 12.53b

0.79 ± 0.08a

V

208.54 ± 48.63b

71.01 ± 17.22ab

0.85 ± 0.14a

a

TBil mg/mL
a

IU/L: International unit/L. AST: aspartate amino transferase, ALT: alanine amino transferase, TBil : total bilirubin, G-I: Control-,
G-II: paracetamol group 10 g/60 kg, G-III: FAL 50 mg/kg, G-IV: FAB 50 mg/kg, G-V: FAL/FAB 50 mg/kg. Each value in the table is the
mean ± (SEM) (n = 8). Values in the same column sharing different letters are significantly different (P < 0.05) (ANOVA followed by
Newman–Keuls).
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controlcontrol+
FAL 50 mg/kg

0.6
MDA concentration (nmol/mg)

63.98 ± 9.45 IU/L for group III and AST = 236.94 ± 27.45
IU/L; ALT = 84.34 ± 12.53 IU/L for group IV) (Table
4). Moreover, FAL extract prevented liver damage much
better than the combined treatment of 25 mg/kg of each
extract (FAB and FAL) (AST = 208.54 ± 48.63 IU/L; ALT
= 71.01 ± 17.22 IU/L) (Table 4, group V). On the other
hand, total bilirubin level was restored to its normal level
completely and equally by all the treatments (1.42 ± 0.35
mg/mL for FAL; 0.79 ± 0.08 mg/mL for FAB and 0.85 ±
0.14 mg/mL for FAL/FAB).
4.5.2. Lipid peroxidation assay
MDA is a widely used marker of free radical-mediated lipid
peroxidation, which explains why a significant increase
(P < 0.05) of MDA (0.45 ± 0.040 nmol/mg liver tissue) in
paracetamol-induced mice was observed compared with
the negative control group (0.12 ± 0.07 nmol/mg liver
tissue) (Figure 5). On the other hand, an ameliorative effect
on the MDA levels (P < 0.05) in groups pretreated with FAL
or FAB extracts (0.290 ± 0.034 and 0.340 ± 0.038 nmol/
mg liver tissue) was noticed. Simultaneous treatment with
both extracts provided even a better hepatoprotective effect
(MDA = 0.250 ± 0.058 nmol/mg liver tissue) (Figure 5).
4.5.3. Histological analysis
Signs of extensive damage in livers of paracetamol-treated
mice were obvious in the histological sections of the
positive control group with massive centrilobular necrosis
(leucocytes infiltration around the centrilobular veins)
and some periportal degeneration (Figure 6). However,
FAL and FAB provided significant protection against
paracetamol-induced damage as the centrilobular area
(i.e. the area in which covalent binding of paracetamol is
preferentially localized) showed only little degeneration
(Figures 6C and 6D). However, less protection was
observed with the simultaneous treatment with both
extracts (6E), which does not fully corroborate with MDA
data.

***
0.4

*

*

FAB 50 mg/kg
FAL/FAB 50 mg/kg

0.2

0.0

Sample

Figure 5. Malondialdehyde (MDA) levels in mice pretreated
with F. angustifolia ethanol leaf and bark extracts. FAL: Fraxinus
angustifolia leaves, FAB: Fraxinus angustifolia barks. All values
are expressed as means ± SEM of six animals. One-way ANOVA
followed by Dunnett’s test was used for statistical signiﬁcance. *P
< 0.05, **P < 0.01, ***P < 0.001 compared with the control group.

5. Discussion
5.1. HPLC analysis
The present HPLC system was able to detect all the
standards as the respective simple peaks with good
resolution (Figure 1A). The most remarkable observation
from this data is that leaf and bark extracts do not share
common chemicals and that all of the compounds with
the exception of luteolin in bark were previously detected
in this species (25,26). Moreover, the occurrence of
secoridoids such as oleuropein and phenylethanoids such
as tyrosol is a characteristic feature of Fraxinus species
(26).
5.2. Determination of total polyphenols and flavonoids
Fraxinus angustifolia is a widely used shrub in folk
medicine in Algeria. Its healing virtues are related to its
high content of natural compounds, mainly polyphenols,

MEDJAHED et al. / Turk J Med Sci

Figure 6. Histological sections of liver (400×). A) Untreated control group. B) Group supplemented with 10 g/60 kg of
paracetamol: inflammatory mass, massive necrosis (B1), centrilobular veins dilated and congested (B2), dilated sinusoids.
C) Group treated with 50 mg/kg of FAL, conserved architecture centrilobular vein dilated, no necrosis. D) Group treated with
50 mg/kg FAB conserved architecture with some necrosis. E) Group treated with leaves/barks extract, some necrosis.

which have been previously quantified (7,27). The results
obtained in those studies are in full agreement with our
findings. Additionally, the Fraxinus genus is described as a
rich source of flavones and flavonols that are derivatives of
quercetin and kaempferol (26). The above HPLC analysis
confirmed the presence of a flavone, luteolin, and a
flavonol, quercetin, in FAB and FAL extracts, respectively.
5.3. Subchronic toxicity
The extent of hepatic injury is assessed by the level of
released cytoplasmic enzymes, AST and ALT, in circulation
(28,29). The unaltered activity of AST, ALT, or bilirubin for
both FAL- and FAB-fed mice (except for a slight rise in ALT
in FAL-treated mice) (45.5 ± 1.8 IU/L) confirmed that the

treatment did not cause hepatocellular injury. In addition,
as revealed by glucose, cholesterol, and creatinine data,
the extracts did not disrupt sugar or lipid metabolisms
and did not cause impairment of kidney function. Aside
from the interest in the efficacy of medicinal plant extracts
against various diseases, safety (short and long term) is an
important factor in traditional medicine. This experiment
showed that the long-term administration of both parts of
F. angustifolia did not present any toxicity.
5.4. Antidiabetic activity
5.4.1. Antidiabetic activity in vivo
The rise in glucose levels in the control positive group was
counteracted by a maximal hypoglycemic effect in the test
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groups, which was observed more specifically in 2 h, and
more so in the case of FAL compared with FAB treatment.
No previous data about the antidiabetic activity of F.
angustifolia was reported, but findings on a related species,
Fraxinus excelsior (12), were less promising because a
single oral administration of an aqueous extract (20 mg/
kg) of this plant reduced blood glucose levels from the
1st (P < 0.01) to the 6th h (P < 0.001) by only 13.6% in
diabetic rats. The cytotoxic activity of STZ on pancreatic
cells is based on the prooxidant action mechanism of STZ,
acting as an NO. donor and causing the fragmentation of
DNA (30). Therefore, we assume that the high tolerance
to glucose observed can be attributed to the antioxidant
activity of the constituent flavonoids of F. angustifolia
as higher amounts of these compounds in leaves led to
higher protective activity against the toxic impact of
STZ compared with that of the bark. The antioxidant
potential of F. angustifolia bark extract was demonstrated
in previous studies (27,31). Moreover, the current study
revealed the presence of a number of phytochemicals that
constitute a major group of compounds that act as primary
antioxidants with high redox potentials and singlet
oxygen quenchers (32). Some of these compounds, such
as quercetin and luteolin, have shown strong antidiabetic
activities (33), which corroborates earlier investigations
that equally established a close relationship between the
antioxidant properties of polyphenolic compounds and
their antidiabetic potential (34,35).
5.4.2. Antidiabetic activity in vitro: α-amylase inhibition
assay
Pancreatic α-amylase catalyzes the initial step in the
hydrolysis of starch, a principal source of glucose in the
diet (36). Therefore, the inhibition of this enzyme by FAL
and FAB extracts would prevent more glucose release
in the blood. The higher inhibition by FAL over FAB
extract observed consolidates the above findings of the
in vivo experiment in which the FAL extract was a more
potent hypoglycemic agent than its bark counterpart.
Moreover, this assay helped to gain some insight on the
possible mechanism of action of F. angustifolia extracts
by revealing that they contain α-amylase inhibitory
metabolites, although other mechanisms cannot be
excluded. In fact, past clinical studies have demonstrated
that phenolic compounds, such as luteolin, that inhibit
carbohydrate-hydrolyzing enzymes decrease postprandial
hyperglycemia in noninsulin-dependent diabetes mellitus
patients; however, it was less potent than acarbose (37).
5.5. Hepatoprotective potential
Paracetamol-induced hepatic injury is a commonly used
experimental model for the screening of hepatoprotective
drugs (38,39). The lesions produced are the result of
the prooxidant effect of paracetamol, affecting blood
parameters.
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5.5.1. Blood parameters
The deleterious effect of paracetamol provoked an increase
in transaminase levels, in agreement with previous
findings (40), as a result of induced acute toxicity and
destruction of liver cells. The administration of the FAL
extract contributed to restoring the transaminase enzyme
activities to their normal level, which was not the case
for the FAB extract, which was insufficient to prevent the
damage to liver cells by paracetamol.
5.5.2. Lipid peroxidation assay
Paracetamol is converted in the liver into its reactive
metabolite N-acetyl [-p-benzo quinine imine] by hepatic
cytochrome P-450 (40–42), leading to massive production
of reactive species and depletion of protective physiological
moieties such as glutathione and α-tocopherol. This
ultimately leads to lipid peroxidation, which causes damage
to the macromolecules in vital biomembranes (43,44),
generating necrosis. Our experiment demonstrated that FAL
was more efficient than FAB extracts in attenuating the MDA
levels (produced as a result of lipid peroxidation). However,
a more prominent effect was observed with simultaneous
treatment, demonstrating a synergistic action between
the compounds of both parts of the plant. HPLC analysis
revealed the presence of some strong antioxidant compounds
in both extracts such as caffeic acid and luteolin in bark and
quercetin in leaves. However, limited information about the
bioactive molecule responsible for the observed synergistic
effect makes its identification imperative and even interesting.
Indeed, knowledge of the molecular structures would help
us gain insight into the mechanisms involved and widen
the perspective of their exploitation in the pharmacological
industry. Moreover, this route constitutes another research
interest of our team in our continuous quest for identification
of natural substances from local medicinal plants. For now,
we can only assume that the counteracting effects of F.
angustifolia against paracetamol toxicity may be due to the
antioxidant potential of the extracts of this plant reported
in an earlier in vitro study (25). The above data revealing
higher quantity of flavonoids in FAL than in FAB may be
an additional proof that the antioxidant character of the leaf
constituents may lie behind their enhanced activity over FAB
against reactive species generated by paracetamol. Patients
with diabetes mellitus are characterized with elevated levels
of oxidative damage and decreased levels of antioxidant
defenses, and are prone to lipid abnormalities due to lipid
peroxidation (45). Oxidative stress puts diabetes patients at
high risk for the development of coronary disease and renal
and liver failures. Treatment strategies that rely on insulin
or Diabenil do not offer an antioxidant machinery to fight
the prooxidant diseases that are associated with diabetes.
Therefore, natural remedies of antioxidant character are good
candidates to fight diabetes and associated problems, keeping
in mind their lack of secondary effects that are common in
modern drugs.
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5.5.3. Histological analysis
The analysis of liver histology concluded that less necrosis
and damage were generated in the extract-treated groups,
and especially in those receiving FAL, compared with
the control group. These results confirmed the above
findings related to MDA and transaminase levels, with the
exception of the group treated with both parts of the plant.
The results of studies on the mechanism of hepatic necrosis
suggest that lesion genesis proceeds in a sequence of events
(46,47). The first can be metabolic activation of a toxic
reactive intermediate as in the case of paracetamol. The
latter might be irreversible destruction of cell components
leading to disturbances in essential biochemical processes.
This means that protection by F. angustifolia extracts
against paracetamol-induced hepatotoxicity might involve
inhibition of oxidative formation and/or detoxification of
the paracetamol reactive metabolite. The high antioxidant
capacities of the extracts (26) are probably implicated in
those mechanisms.

In conclusion, the present work demonstrated that
leaf and bark extracts of F. angustifolia are safe for use in
folk medicine. It also shed light on their antidiabetic and
hepatoprotective potentials, revealing higher activities
for leave extracts than for their bark counterparts, which
can be accounted for by their higher flavonoid content.
The antioxidant power of flavonoids are surely implicated
in the hepatoprotective potential of the plant and
partially involved in its hypoglycemic action since other
mechanisms, such as the inhibition of α-amylase, can
play a considerable role. Therefore, F. angustifolia extracts
might be considered for use in association with insulin
therapy to alleviate the adverse side effects caused by that
drug.
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